{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T10:57:19Z","timestamp":1770202639452,"version":"3.49.0"},"reference-count":25,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpharmsci.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.xphs.2025.103981","type":"journal-article","created":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T15:02:58Z","timestamp":1756479778000},"page":"103981","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Exploring a new approach in biopharmaceutics to improve the estimation of stomach solubilization from the mathematical model with a single stomach compartment setting: The impact of stomach solubilization on the food effect of quazepam"],"prefix":"10.1016","volume":"114","author":[{"given":"Jia","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael J.","family":"Dolton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4635-5109","authenticated-orcid":false,"given":"Karthik","family":"Nagapudi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-4046-7223","authenticated-orcid":false,"given":"Po-Chang","family":"Chiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.xphs.2025.103981_bib0001","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1023\/A:1015927004752","article-title":"Estimating human oral fraction dose absorbed: a correlation using rat intestinal membrane permeability for passive and carrier-mediated compounds","volume":"5","author":"Amidon","year":"1988","journal-title":"Pharm Res"},{"key":"10.1016\/j.xphs.2025.103981_bib0002","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/0169-409X(96)00009-9","article-title":"Transport approaches to the biopharmaceutical design of oral drug delivery systems: prediction of intestinal absorption","volume":"19","author":"Yu","year":"1996","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.xphs.2025.103981_bib0003","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1023\/A:1015892621261","article-title":"Predicting fraction dose absorbed in humans using a macroscopic mass balance approach","volume":"8","author":"Sinko","year":"1991","journal-title":"Pharm Res"},{"key":"10.1016\/j.xphs.2025.103981_bib0004","first-page":"75","article-title":"In vitro testing of drug absorption for drug \u2018developability\u2019 assessment: forming an interface between in vitro preclinical data and clinical outcome","volume":"7","author":"Sun","year":"2004","journal-title":"Curr Opin Drug Discov Dev"},{"key":"10.1016\/j.xphs.2025.103981_bib0005","series-title":"Optimizing the \u201cDrug-Like\u201d Properties of Leads in Drug Discovery","first-page":"151","article-title":"Biopharmaceutics modeling and the role of dose and formulation on oral exposure","volume":"Vol. IV","author":"Rohrs","year":"2006"},{"key":"10.1016\/j.xphs.2025.103981_bib0006","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1208\/s12248-009-9144-x","article-title":"Prediction of solubility and permeability class membership: provisional BCS classification of the world\u2019s top oral drugs","volume":"11","author":"Dahan","year":"2009","journal-title":"AAPS J"},{"key":"10.1016\/j.xphs.2025.103981_bib0007","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1023\/A:1018999130076","article-title":"Mass balance approaches for estimating the intestinal absorption and metabolism of peptides and analogues: theoretical development and applications","volume":"10","author":"Sinko","year":"1993","journal-title":"Pharm Res"},{"key":"10.1016\/j.xphs.2025.103981_bib0008","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1002\/jps.2600740523","article-title":"Absorption potential: estimating the fraction absorbed for orally administered compounds","volume":"74","author":"Dressman","year":"1985","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.xphs.2025.103981_bib0009","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1023\/A:1016212804288","article-title":"A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability","volume":"12","author":"Amidon","year":"1995","journal-title":"Pharm Res"},{"key":"10.1016\/j.xphs.2025.103981_bib0010","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1023\/A:1018911728161","article-title":"An integrated model for determining causes of poor oral drug absorption","volume":"16","author":"Yu","year":"1999","journal-title":"Pharm Res"},{"key":"10.1016\/j.xphs.2025.103981_bib0011","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0378-5173(99)00147-7","article-title":"A compartmental absorption and transit model for estimating oral drug absorption","volume":"186","author":"Yu","year":"1999","journal-title":"Int J Pharm"},{"key":"10.1016\/j.xphs.2025.103981_bib0012","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1023\/A:1018947113238","article-title":"Estimating the fraction dose absorbed from suspensions of poorly soluble compounds in humans: a mathematical model","volume":"10","author":"Oh","year":"1993","journal-title":"Pharm Res"},{"issue":"4","key":"10.1016\/j.xphs.2025.103981_bib0013","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1208\/s12248-013-9519-x","article-title":"Incorporation of physiologically based pharmacokinetic modeling in the evaluation of solubility requirements for the salt selection process: a case study using Phenytoin. 2013","volume":"15","author":"Chiang","year":"2013","journal-title":"AAPS J"},{"issue":"11","key":"10.1016\/j.xphs.2025.103981_bib0014","doi-asserted-by":"crossref","first-page":"3980","DOI":"10.1021\/mp400088q","article-title":"Systemic concentrations can limit the oral absorption of poorly soluble drugs: an investigation of non-sink permeation using physiologically based pharmacokinetic modeling","volume":"10","author":"Chiang","year":"2013","journal-title":"Mole Pharm"},{"key":"10.1016\/j.xphs.2025.103981_bib0015","series-title":"Biopharmaceutics Modeling and Simulations\u202f: Theory, Practice, Methods, and Applications","author":"Sugano","year":"2012"},{"issue":"7","key":"10.1016\/j.xphs.2025.103981_bib0016","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1016\/j.xphs.2018.03.015","article-title":"Exploring a kinetic model approach in biopharmaceutics: estimating the fraction absorbed of orally administered drugs in humans","volume":"107","author":"Chiang","year":"2018","journal-title":"J Pharm Sci"},{"issue":"7","key":"10.1016\/j.xphs.2025.103981_bib0017","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1016\/j.xphs.2023.02.009","article-title":"Exploring the use of a kinetic pH calculation to correct the ACAT model with a single stomach compartment setting: impact of stomach setting on food effect prediction for basic compounds","volume":"112","author":"Chiang","year":"2023","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.xphs.2025.103981_bib0018","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/j.1365-2982.1993.tb00131.x","article-title":"The relationship between gastric pH and the emptying of solid, semisolid and liquid meals","volume":"5","author":"Clark","year":"1993","journal-title":"Neurogastroenterol Motil"},{"issue":"6","key":"10.1016\/j.xphs.2025.103981_bib0019","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1007\/s11095-016-1882-8","article-title":"Characteristics of the Human upper gastrointestinal contents in the fasted State under hypo- and A-chlorhydric gastric conditions under conditions of typical drug - drug interaction studies","volume":"33","author":"Litou","year":"2016","journal-title":"Pharm Res"},{"issue":"7","key":"10.1016\/j.xphs.2025.103981_bib0020","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1023\/A:1015827908309","article-title":"Upper gastrointestinal (GI) pH in young, healthy men and women","volume":"7","author":"Dressman","year":"1990","journal-title":"Pharm Res"},{"issue":"Pt A","key":"10.1016\/j.xphs.2025.103981_bib0021","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.jconrel.2015.10.022","article-title":"Intragastric pH and pressure profiles after intake of the high-caloric, high-fat meal as used for food effect studies","volume":"220","author":"Koziolek","year":"2015","journal-title":"J Control Release: Off J Control Release Soc"},{"issue":"2","key":"10.1016\/j.xphs.2025.103981_bib0022","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1152\/japplphysiol.00956.2001","article-title":"Measurement of meal-stimulated gastric acid secretion by in vivo gastric autotitration","volume":"92","author":"Gardner","year":"2002","journal-title":"J Appl Physiol (Bethesda Md: 1985)"},{"issue":"5","key":"10.1016\/j.xphs.2025.103981_bib0023","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1002\/bdd.2510160502","article-title":"Comparison of the gastrointestinal anatomy, physiology, and biochemistry of humans and commonly used laboratory animals","volume":"16","author":"Kararli","year":"1995","journal-title":"Biopharm Drug Dispos"},{"issue":"12","key":"10.1016\/j.xphs.2025.103981_bib0024","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1177\/0091270002042012004","article-title":"Effect of dietary fat content in meals on pharmacokinetics of quazepam","volume":"42","author":"Yasui-Furukori","year":"2002","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.xphs.2025.103981_bib0025","article-title":"Strategies in drug delivery: strategies in drug delivery:intestines to intracellular organelles","volume":"1","author":"Yamashita","year":"2006","journal-title":"Univ Kans Short-course"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354925004356?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354925004356?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T19:03:21Z","timestamp":1769713401000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354925004356"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":25,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S0022354925004356"],"URL":"https:\/\/doi.org\/10.1016\/j.xphs.2025.103981","relation":{},"ISSN":["0022-3549"],"issn-type":[{"value":"0022-3549","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exploring a new approach in biopharmaceutics to improve the estimation of stomach solubilization from the mathematical model with a single stomach compartment setting: The impact of stomach solubilization on the food effect of quazepam","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xphs.2025.103981","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 American Pharmacists Association. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"103981"}}